| Q37229700 | A practical approach to using spot urine protein/creatinine ratios for assessing proteinuria in pregnancy |
| Q33820373 | A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy |
| Q35888426 | A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia |
| Q47986851 | Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy. |
| Q41525954 | Bedside diagnostic testing of body fluids |
| Q37291519 | Burden of Hypertension and Abnormal Glomerular Permeability in Hypertensive School Children |
| Q73413245 | Change in paternity: a risk factor for preeclampsia in multiparous women? |
| Q51039062 | Clinical utility of trace proteinuria for microalbuminuria screening in the general population. |
| Q44738156 | Comparing ambulatory spot urine protein/creatinine ratios and 24-h urine protein measurements in normal pregnancies |
| Q36083010 | Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. |
| Q37630424 | Dipstick proteinuria level is significantly associated with pre-morbid and in-hospital functional status among hospitalized older adults: a preliminary study. |
| Q46640194 | Does microalbuminuria at mid-pregnancy predict development of subsequent pre-eclampsia? |
| Q33329194 | Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity |
| Q44014214 | Effect of concentration and biochemical assay on the accuracy of urine dipsticks in hypertensive pregnancies |
| Q53686437 | Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. |
| Q34177612 | How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence |
| Q37565702 | Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy |
| Q35077076 | Interbirth interval and history of previous preeclampsia: a case-control study among multiparous women |
| Q34224924 | Management and monitoring of severe preeclampsia |
| Q51526675 | Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy. |
| Q62898824 | PARROT Ireland: Placental growth factor in Assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol |
| Q37388279 | Pharmacotherapeutic options for the treatment of preeclampsia |
| Q33416340 | Pre-eclampsia part 1: current understanding of its pathophysiology |
| Q51874099 | Predicting proteinuria in pregnancy: a potential algorithm. |
| Q44862095 | Predictive value of 3+ spot urinary protein value measured by dipstick in hypertensive pregnant patients |
| Q35171695 | Prenatal screening, epidemiology, diagnosis, and management of preeclampsia |
| Q33548012 | Prevention of preeclampsia |
| Q43793017 | Problems in methods for the detection of significant proteinuria in pregnancy |
| Q91816405 | Protein Misfolding during Pregnancy: New Approaches to Preeclampsia Diagnostics |
| Q45266624 | Proteinuria in pre-eclampsia: how much matters? |
| Q33382592 | Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia |
| Q50773584 | Random albumin/creatinine ratio for quantification of proteinuria in manifest pre-eclampsia. |
| Q37199913 | Random urine protein/creatinine ratio readily predicts proteinuria in preeclampsia |
| Q73178937 | Reliable urine analysis in the management of hypertensive pregnancies |
| Q46343919 | Report of 50 cases of eclampsia |
| Q77880673 | Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia |
| Q34976710 | Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes |
| Q33330818 | Severe uterine diastolic notch as a prognostic factor in preeclamptic women |
| Q51393521 | The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy. |
| Q33990742 | The detection, investigation and management of hypertension in pregnancy: full consensus statement |
| Q40973002 | The pharmacological prevention of pre-eclampsia |
| Q33864822 | The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification |
| Q71949088 | The value of routine urine dipstick screening for protein at each prenatal visit |
| Q37345670 | Urinalysis vs urine protein-creatinine ratio to predict significant proteinuria in pregnancy |
| Q36830967 | Urinary Protein Creatinine Ratio in Normal Zero to Three-Day-Old Indian Neonates |
| Q47345092 | Urinary creatinine excretion and protein/creatinine ratios vary by body size and gender in children |
| Q35868632 | Urinary protein-to-creatinine ratio in pregnant women after dipstick testing: prospective observational study |
| Q46786406 | Urine protein estimation in hypertensive pregnancy: which thresholds and laboratory assay best predict clinical outcome? |
| Q46605374 | Using protein/creatinine ratios in random urine. |
| Q44369605 | Validation of the DCA 2000 microalbumin:creatinine ratio urinanalyzer for its use in pregnancy and preeclampsia |
| Q46786396 | Variation in the urinary protein/creatinine ratio at four different periods of the day in hypertensive pregnant women |
| Q28196892 | What we have learned about preeclampsia |